Werewolf Therapeutics, Inc.
HOWLNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $47.63M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.27$1.83
- Volume (live)
- -
- Avg. volume (3M)
- 562.98K
Werewolf Therapeutics (HOWL) Stock Price & Financial Analysis
Werewolf Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.95 - $1.00 |
|---|---|
| 52-Week High | $1.83 |
| 52-Week Low | $0.27 |
| Open | $0.99 |
| Volume (last close) | 477.44K |
| Average Volume (3M) | 562.98K |
| Revenue (TTM) | 21.00M |
|---|---|
| Net Income (TTM) | -34.61M |
| Free Cash Flow (TTM) | -30.15M |
| EPS (TTM) | −$0.73 |
| Profit Margin | -164.82% |
| Operating Margin | -128.34% |
| Return on Equity (ROE) | -212.45% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 47.63M |
|---|---|
| Shares Outstanding | 48.60M |
| Price to Sales (P/S) | 2.27 |
| Price to Book (P/B) | 2.92 |
| EV/EBITDA | -1.23 |
| 50-Day MA | $0.87 |
|---|---|
| 200-Day MA | $0.67 |
| 1-Year Change | −35.67% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Werewolf Therapeutics at a Glance
As of the Oct 26, 2026 close, Werewolf Therapeutics (HOWL) has a market capitalization of $47.63M. The stock trades at 2.3× sales. Over the trailing twelve months it lost $34.61M on revenue of $21.00M and burned $30.15M of free cash flow. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $21.99M in cash and securities against $0.00 of debt, a net cash position of $21.99M.
Werewolf Therapeutics does not currently pay a dividend.
The share price is down 35.7% over the past year. At $0.98 (the Oct 26, 2026 close) it sits within its 52-week range of $0.27 to $1.83, above its 200-day moving average of $0.67.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Werewolf Therapeutics
What is the current stock price for HOWL?
As of the Oct 26, 2026 close, HOWL stock trades at $0.98. The 52-week range is $0.27–$1.83, with a day range of $0.95–$1.00.
What is the P/E ratio for HOWL?
The P/E ratio (Price-to-Earnings) for HOWL is shown in the Key Statistics section. This valuation metric helps compare Werewolf Therapeutics, Inc. to industry peers.
Does HOWL pay dividends?
Werewolf Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for HOWL?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for HOWL is Buy.
What is the market cap of HOWL?
As of the Oct 26, 2026 close, Werewolf Therapeutics's market capitalization is $47.7M, classifying it as a micro-cap company. Werewolf Therapeutics operates in the Healthcare sector within the Biotechnology industry.